Sign in
4

Changes in Ownership

RESMED INC Filed Acc 0001127602-21-016280

Chief Financial Officer sold 2,500 shares at $196.00 ($490,000)

From the SEC's structured data for this filing

Trades in this filing

Sandercock Brett · Chief Financial Officer

Table I: Non-derivative

1 line
Date Transaction Shares Price Value Owned after D/I
2021-05-10 Sale : show line 1 in the form −2,500 $196.00 $490,000 92,502 D
Open-market sales · 2,500 sh · avg $196.00 · $490,000
Loading xslF345X03/form4.xml…